13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q3 2022. See the latest, Q2 2026 →
Reported value
$469.49B
−5.5% on the quarter before
Positions
2,019
206 new · 243 sold out
Top 10
18.1%
of the value
Est. gain
−$22.76B
on stocks held all quarter
Est. return
−4.9%
on those stocks since Q2 2022
Positions as of Sep 30, 2022, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 31% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2022. Striped tiles are options.
Largest buys
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amazon~$1.66BAdded · 1.3% → 1.8%+14,685,084 shares
- Eog Res Inc~$843.3MAdded · 0.2% → 0.4%+7,547,669 shares
- Nextera Energy Inc~$788.2MAdded · 0.1% → 0.2%+10,052,347 shares
- Atmos Energy Corp~$758.9MNew · 0.0% → 0.2%+7,450,908 shares
- Conocophillips~$730.4MAdded · 0.6% → 0.9%+7,137,017 shares
- Tjx Cos Inc New~$639.9MAdded · 1.2% → 1.5%+10,300,555 shares
- Nike Inc~$561.9MAdded · 0.5% → 0.6%+6,760,308 shares
- Welltower Inc~$507.3MAdded · 0.3% → 0.4%+7,886,464 shares
- Rio Tinto Plc~$493.9MAdded · 0.1% → 0.2%+8,969,873 shares
- Qualcomm~$493.3MAdded · 0.2% → 0.3%+4,366,311 shares
Largest sells
Since Q2 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Progressive Corp~$1.15BCut · 0.7% → 0.5%−9,934,838 shares
- Mondelez Intl Inc~$860.2MCut · 0.5% → 0.3%−15,689,153 shares
- Verizon Communications Inc~$785.7MCut · 0.3% → 0.1%−20,693,259 shares
- BlackRock~$689.6MCut · 0.4% → 0.2%−1,253,101 shares
- Dominion Energy~$670.4MCut · 0.3% → 0.1%−9,700,925 shares
- Unitedhealth Group Inc~$670.0MCut · 2.7% → 2.7%−1,326,641 shares
- Jpmorgan Chase & Co~$642.3MCut · 1.0% → 0.8%−6,146,641 shares
- Procter And Gamble Co~$585.5MCut · 1.2% → 1.0%−4,637,443 shares
- Viatris Inc~$578.3MSold out · 0.1% → 0.0%−55,233,099 shares
- Mcdonalds Corp~$559.8MCut · 1.0% → 0.9%−2,425,969 shares
Holdings
As of Sep 30, 2022. Changes are in shares against Jun 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +0.1% · price −9.3% | 3.2% | $14.95B | −$1.53B | ||||||||
| Unitedhealth Group IncCOM · shares −5.0% · price −1.7% | 2.7% | $12.73B | −$216.6M | ||||||||
| AppleCOM · shares +1.3% · price +1.1% | 2.0% | $9.29B | +$98.2M | ||||||||
| Pfizer IncCOM · shares −3.8% · price −16.5% | 2.0% | $9.23B | −$1.83B | ||||||||
| AmazonCOM · shares +25% · price +6.4% | 1.8% | $8.32B | +$400.3M | ||||||||
| Eli LillyCOM · shares −6.8% · price −0.3% | 1.5% | $7.06B | −$19.2M | ||||||||
| Tjx Cos Inc NewCOM · shares +10% · price +11.2% | 1.5% | $7.01B | +$642.9M | ||||||||
| AlphabetCAP STK CL A · shares +0.3% · price −21.0% | 1.3% | $6.17B | −$1.64B | ||||||||
| Schwab Charles CorpCOM · shares −0.4% · price +13.8% | 1.2% | $5.42B | +$655.4M | ||||||||
| Danaher CorporationCOM · shares −0.01% · price +1.9% | 1.0% | $4.90B | +$90.5M | ||||||||
| Texas InstrumentsCOM · shares −10% · price +0.7% | 1.0% | $4.72B | +$34.5M | ||||||||
| Procter And Gamble CoCOM · shares −11% · price −12.2% | 0.99% | $4.64B | −$644.8M | ||||||||
| Johnson & JohnsonCOM · shares −5.2% · price −8.0% | 0.97% | $4.57B | −$396.0M | ||||||||
| MastercardCL A · shares +0.01% · price −9.9% | 0.94% | $4.43B | −$485.3M | ||||||||
| ConocophillipsCOM · shares +20% · price +14.0% | 0.94% | $4.40B | +$449.0M | ||||||||
| Humana IncCOM · shares −4.5% · price +3.7% | 0.93% | $4.35B | +$153.7M | ||||||||
| Visa Inc.COM CL A · shares +1.0% · price −9.8% | 0.89% | $4.19B | −$449.5M | ||||||||
| Elevance Health IncCOM · shares −6.6% · price −5.9% | 0.89% | $4.18B | −$260.8M | ||||||||
| Home Depot IncCOM · shares +6.5% · price +0.6% | 0.87% | $4.07B | +$23.1M | ||||||||
| Mcdonalds CorpCOM · shares −12% · price −6.5% | 0.85% | $4.00B | −$279.6M | ||||||||
| Jpmorgan Chase & CoCOM · shares −14% · price −7.2% | 0.85% | $3.99B | −$309.3M | ||||||||
| Morgan StanleyCOM NEW · shares +11% · price +3.9% | 0.83% | $3.89B | +$130.8M | ||||||||
| Chubb LimitedCOM · shares −12% · price −7.5% | 0.81% | $3.82B | −$308.4M | ||||||||
| Coca Cola CoCOM · shares −4.9% · price −11.0% | 0.78% | $3.67B | −$451.3M | ||||||||
| Stryker CorporationCOM · shares +7.8% · price +1.8% | 0.76% | $3.57B | +$59.1M | ||||||||
| Total · 2,019 positions | 100% | $469.49B | −$22.76B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2022 to Q3 2022: 1,731 stocks held throughout, down $22.76B (−4.9%).
- Schwab Charles Corp+$655.4M+14%
- Tjx Cos Inc New+$642.9M+11%
- Conocophillips+$449.0M+14%
- Amazon+$400.3M+6%
- Biogen Inc+$323.9M+31%
- Alphabet17:1 split−$657.8M−25%
- Exelon Corporation−$709.7M−17%
- Microsoft−$1.53B−9%
- Alphabet18:1 split−$1.64B−21%
- Pfizer Inc−$1.83B−17%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 7 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |